Actionable news
All posts from Actionable news
Actionable news in BIIB: Biogen Idec Inc.,

Biogen (BIIB) Upgraded to 'Buy' at Piper, Analysts Weigh In

NEW YORK (TheStreet) --Shares of Biogen (BIIB) were climbing by 6.81% to $295.86 in early afternoon trading on Monday, after Piper Jaffray upgraded the stock to "buy" from "neutral" with a price target of $335. "While there may be more trouble ahead, the valuation seems like a reasonable entry," according to the firm.

"Part of their thesis seems to be Alzheimer's research, a lot of companies have failed to make any progress in Alzheimer's, so they may be wrong in that regard," Lebenthal Asset Management CEO Jim Lebenthal said during CNBC's "Fast Money Halftime...